Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis

John P. Fitzgerald, Barbara Ercole, Dipen J Parekh

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.

Original languageEnglish
Pages (from-to)98-101
Number of pages4
JournalIndian Journal of Urology
Volume26
Issue number1
DOIs
StatePublished - Jan 1 2010
Externally publishedYes

Fingerprint

Testis
Drug Therapy
Germ Cell and Embryonal Neoplasms
Standard of Care
Patient Selection
Therapeutics
Nonseminomatous germ cell tumor

Keywords

  • Cancer
  • Testis

ASJC Scopus subject areas

  • Urology

Cite this

Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis. / Fitzgerald, John P.; Ercole, Barbara; Parekh, Dipen J.

In: Indian Journal of Urology, Vol. 26, No. 1, 01.01.2010, p. 98-101.

Research output: Contribution to journalArticle

@article{484bfa779ca34a9e9771b788b4fcd147,
title = "Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis",
abstract = "The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.",
keywords = "Cancer, Testis",
author = "Fitzgerald, {John P.} and Barbara Ercole and Parekh, {Dipen J}",
year = "2010",
month = "1",
day = "1",
doi = "10.4103/0970-1591.60448",
language = "English",
volume = "26",
pages = "98--101",
journal = "Indian Journal of Urology",
issn = "0970-1591",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "1",

}

TY - JOUR

T1 - Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis

AU - Fitzgerald, John P.

AU - Ercole, Barbara

AU - Parekh, Dipen J

PY - 2010/1/1

Y1 - 2010/1/1

N2 - The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.

AB - The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.

KW - Cancer

KW - Testis

UR - http://www.scopus.com/inward/record.url?scp=77950572150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950572150&partnerID=8YFLogxK

U2 - 10.4103/0970-1591.60448

DO - 10.4103/0970-1591.60448

M3 - Article

C2 - 20535294

AN - SCOPUS:77950572150

VL - 26

SP - 98

EP - 101

JO - Indian Journal of Urology

JF - Indian Journal of Urology

SN - 0970-1591

IS - 1

ER -